EUCREAS

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug EUCREAS contains a combination of these active pharmaceutical ingredients (APIs):

1 Vildagliptin UNII I6B4B2U96P - VILDAGLIPTIN

Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Read about Vildagliptin

2 Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EUCREAS Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BD08	Metformin and vildagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1349322, 1349333, 1349344, 1349355, 1349366, 1349377, 1349388, 1349399, 1349401, 1349412, 1349423, 1349434
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07425003, 07425003IP, 07425003IP1, 07425003IP2, 07425009, 07425009IP, 07425009IP1, 07425009IP2, 07425021IP, 07425021IP1, 07425027IP, 07425027IP1
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 079885, 182805
Country: FR	Base de données publique des médicaments	Identifier(s): 60892792
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 134124, 134127, 198740, 374363, 376366, 379891
Country: IE	Health Products Regulatory Authority	Identifier(s): 24314, 24352, 24353
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6290, 7015, 7199
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028176, 1028177, 1028178, 1028179, 1028180, 1028181, 1028182, 1028183, 1028184, 1028185, 1028186, 1028187, 1028188, 1028189, 1028190, 1028191, 1028192, 1028193, 1077885, 1077886, 1077887, 1077888, 1077889, 1077890, 1077891, 1077892, 1077893, 1077894, 1077895, 1077896, 1077897, 1077898, 1077899, 1077900, 1077901, 1077902, 1091014, 1091015, 1091016, 1091017, 1091018, 1091019, 1091020, 1091021, 1091022, 1091023, 1091024, 1091025, 1091026, 1091027, 1091028, 1091029, 1091030, 1091031
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 85952, 85960
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100182274, 100182280
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64469001, W64469002, W64469003, W64469004, W64469005, W64469006, W64469007, W64469008, W64469009, W64470001, W64470002, W64470003, W64470004, W64470005, W64470006, W64470007, W64470008, W64470009